Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5451
PUT
JFrog
FROG
$11.5B
| $1.99M | ﹤0.01% |
94,600
-257,900
| -73% | -$5.41M |
|
5452
PUT
Invesco NASDAQ 100 ETF
QQQM
$106B
| $1.99M | ﹤0.01% |
17,300
-18,900
| -52% | -$2.41M |
|
5453
Schwab 5-10 Year Corporate Bond ETF
SCHI
$11.5B
| $1.99M | ﹤0.01% |
89,420
+42,550
| +91% | +$967K |
|
|
CMAX
5454
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $1.99M | ﹤0.01% |
18,291
+14,182
| +345% | +$2.43M |
|
5455
PUT
BlueLinx
BXC
$665M
| $1.99M | ﹤0.01% |
29,800
-68,100
| -70% | -$5.12M |
|
5456
Stratasys
SSYS
$758M
| $1.99M | ﹤0.01% |
106,252
-67,325
| -39% | -$1.33M |
|
5457
ICU Medical
ICUI
$4.6B
| $1.99M | ﹤0.01% |
12,106
+6,173
| +104% | +$1.19M |
|
5458
CALL
FIGS
FIGS
$2.42B
| $1.99M | ﹤0.01% |
218,200
+4,400
| +2% | +$56.1K |
|
5459
CALL
Red Rock Resorts
RRR
$3.73B
| $1.99M | ﹤0.01% |
59,600
+11,300
| +23% | +$452K |
|
|
RWT
5460
CALL
Redwood Trust
RWT
$605M
| $1.99M | ﹤0.01% |
257,900
+161,900
| +169% | +$1.49M |
|
5461
CALL
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.71B
| $1.99M | ﹤0.01% |
24,500
+5,800
| +31% | +$489K |
|
5462
Brixmor Property Group
BRX
$9.14B
| $1.99M | ﹤0.01% |
98,271
-394,488
| -80% | -$9.33M |
|
5463
WisdomTree US SmallCap Earnings Fund
EES
$735M
| $1.99M | ﹤0.01% |
+48,287
| New | +$2.15M |
|
5464
Tucows
TCX
$118M
| $1.98M | ﹤0.01% |
44,578
+34,161
| +328% | +$1.81M |
|
5465
CALL
Grab
GRAB
$14.9B
| $1.98M | ﹤0.01% |
783,500
-92,600
| -11% | -$266K |
|
5466
Kura Oncology
KURA
$990M
| $1.98M | ﹤0.01% |
108,134
-45,599
| -30% | -$656K |
|
5467
CALL
Performance Food Group
PFGC
$16.5B
| $1.98M | ﹤0.01% |
43,100
-22,500
| -34% | -$1.04M |
|
5468
WisdomTree Yield Enhanced US Short-Term Aggregate Bond Fund
SHAG
$47.3M
| $1.98M | ﹤0.01% |
41,644
+7,562
| +22% | +$361K |
|
|
ESGR
5469
DELISTED
Enstar Group
ESGR
| $1.98M | ﹤0.01% |
9,241
+4,105
| +80% | +$954K |
|
|
FLAC
5470
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
| $1.98M | ﹤0.01% |
200,080
-353,188
| -64% | -$3.48M |
|
5471
CALL
Bio-Techne
TECH
$11.3B
| $1.98M | ﹤0.01% |
22,800
-26,000
| -53% | -$2.44M |
|
5472
CALL
Invesco CurrencyShares British Pound Sterling Trust
FXB
$65.2M
| $1.98M | ﹤0.01% |
16,900
+13,400
| +383% | +$1.62M |
|
5473
Quanterix
QTRX
$131M
| $1.97M | ﹤0.01% |
121,913
+69,004
| +130% | +$1.42M |
|
5474
CALL
Trinity Industries
TRN
$2.4B
| $1.97M | ﹤0.01% |
81,500
+40,700
| +100% | +$1.1M |
|
|
RPTX
5475
DELISTED
Repare Therapeutics
RPTX
| $1.97M | ﹤0.01% |
141,020
+82,093
| +139% | +$967K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.